Meridian Medical Technologies lands $130m Pentagon deal for nerve agent antidotes

The U.S. Defense Dept. agrees to pay Meridian Medical Technologies $130 million to develop auto-injectors that can deliver nerve agent antidotes.

Maryland's Meridian Medical Technologies is moving ahead with a whopping $129.5 million U.S. government contract to develop auto-injectors that can deliver nerve agent antidotes.

Meridian Medical Technologies, U.S. Defense Dept.

News Well

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Cahb6E